|
1.
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: GLOBOCAN 2008 v2.0, Cancer Incidence and
Mortality Worldwide: IARC CancerBase No 10 [Internet]. Lyon,
France: International Agency for Research on Cancer; 2010,
http://globocan.iarc.fr.
accessed on February 27, 2012.
|
|
2.
|
Alberts SR, Cervantes A and van de Velde
CJ: Gastric cancer: epidemiology, pathology and treatment. Ann
Oncol. 14(Suppl 2): ii31–36. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
|
4.
|
Hyung WJ, Noh SH, Yoo CH, et al:
Prognostic significance of metastatic lymph node ratio in T3
gastric cancer. World J Surg. 26:323–329. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Nathan C and Ding A: Nonresolving
inflammation. Cell. 140:871–882. 2010. View Article : Google Scholar
|
|
7.
|
Mantovani A: Cancer: Inflaming metastasis.
Nature. 457:36–37. 2009. View
Article : Google Scholar
|
|
8.
|
Righi E, Kashiwagi S, Yuan J, et al:
CXCL12/CXCR4 blockade induces multimodal antitumor effects that
prolong survival in an immunocompetent mouse model of ovarian
cancer. Cancer Res. 71:5522–5534. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Wendel C, Hemping-Bovenkerk A, Krasnyanska
J, et al: CXCR4/CXCL12 participate in extravasation of
metastasizing breast cancer cells within the liver in a rat model.
PLoS One. 7:e300462012. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Balkwill FR: The chemokine system and
cancer. J Pathol. 226:148–157. 2012. View Article : Google Scholar
|
|
11.
|
Lazennec G and Richmond A: Chemokines and
chemokine receptors: new insights into cancer-related inflammation.
Trends Mol Med. 16:133–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Murphy PM: The molecular biology of
leukocyte chemoattractant receptors. Annu Rev Immunol. 12:593–633.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kelvin DJ, Michiel DF, Johnston JA, et al:
Chemokines and serpentines: the molecular biology of chemokine
receptors. J Leukoc Biol. 54:604–612. 1993.PubMed/NCBI
|
|
14.
|
Waugh DJ and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Zhang Y, Wang L, Zhang M, Jin M, Bai C and
Wang X: Potential mechanism of interleukin-8 production from lung
cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway. J
Cell Physiol. 227:35–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Ginestier C, Liu S, Diebel ME, et al:
CXCR1 blockade selectively targets human breast cancer stem cells
in vitro and in xenografts. J Clin Invest. 120:485–497. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Singh S, Nannuru KC, Sadanandam A, Varney
ML and Singh RK: CXCR1 and CXCR2 enhances human melanoma
tumourigenesis, growth and invasion. Br J Cancer. 100:1638–1646.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Varney ML, Singh S, Li A, Mayer-Ezell R,
Bond R and Singh RK: Small molecule antagonists for CXCR2 and CXCR1
inhibit human colon cancer liver metastases. Cancer Lett.
300:180–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Matsuo Y, Raimondo M, Woodward TA, et al:
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro
and in vivo in pancreatic cancer. Int J Cancer. 125:1027–1037.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Eck M, Schmausser B, Scheller K, Brändlein
S and Müller-Hermelink HK: Pleiotropic effects of CXC chemokines in
gastric carcinoma: differences in CXCL8 and CXCL1 expression
between diffuse and intestinal types of gastric carcinoma. Clin Exp
Immunol. 134:508–515. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Wang JP, Hu WM, Wang KS, et al:
Upregulation of C-X-C chemokine receptor type 1 expression is
associated with late-stage gastric adenocarcinoma. Exp Ther Med.
4:55–60. 2012.PubMed/NCBI
|
|
22.
|
Washington K: 7th edition of the AJCC
cancer staging manual: stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Allred DC, Harvey JM, Berardo M and Clark
GM: Prognostic and predictive factors in breast cancer by
immunohistochemical analysis. Mod Pathol. 11:155–168.
1998.PubMed/NCBI
|
|
24.
|
Harvey JM, Clark GM, Osborne CK and Allred
DC: Estrogen receptor status by immunohistochemistry is superior to
the ligand-binding assay for predicting response to adjuvant
endocrine therapy in breast cancer. J Clin Oncol. 17:1474–1481.
1999.PubMed/NCBI
|
|
25.
|
Raman D, Baugher PJ, Thu YM and Richmond
A: Role of chemokines in tumor growth. Cancer Lett. 256:137–165.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ali S and Lazennec G: Chemokines: novel
targets for breast cancer metastasis. Cancer Metastasis Rev.
26:401–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Vindrieux D, Escobar P and Lazennec G:
Emerging roles of chemokines in prostate cancer. Endocr Relat
Cancer. 16:663–673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Orimo A, Gupta PB, Sgroi DC, et al:
Stromal fibroblasts present in invasive human breast carcinomas
promote tumor growth and angiogenesis through elevated SDF-1/CXCL12
secretion. Cell. 121:335–348. 2005. View Article : Google Scholar
|
|
29.
|
Colmone A, Amorim M, Pontier AL, Wang S,
Jablonski E and Sipkins DA: Leukemic cells create bone marrow
niches that disrupt the behavior of normal hematopoietic progenitor
cells. Science. 322:1861–1865. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Singh S, Varney M and Singh RK: Host
CXCR2-dependent regulation of melanoma growth, angiogenesis, and
experimental lung metastasis. Cancer Res. 69:411–415. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Kitamura T, Kometani K, Hashida H, et al:
SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that
promote invasion. Nat Genet. 39:467–475. 2007.
|
|
32.
|
Buonamici S, Trimarchi T, Ruocco MG, et
al: CCR7 signalling as an essential regulator of CNS infiltration
in T-cell leukaemia. Nature. 459:1000–1004. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Maxwell PJ, Gallagher R, Seaton A, et al:
HIF-1 and NF-kappa B-mediated upregulation of CXCR1 and CXCR2
expression promotes cell survival in hypoxic prostate cancer cells.
Oncogene. 26:7333–7345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Varney ML, Li A, Dave BJ, Bucana CD,
Johansson SL and Singh RK: Expression of CXCR1 and CXCR2 receptors
in malignant melanoma with different metastatic potential and their
role in interleukin-8 (CXCL-8)-mediated modulation of metastatic
phenotype. Clin Exp Metastasis. 20:723–731. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Varney ML, Johansson SL and Singh RK:
Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and
their association with vessel density and aggressiveness in
malignant melanoma. Am J Clin Pathol. 125:209–216. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Murphy C, McGurk M, Pettigrew J, et al:
Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and
CXCR2 correlates with cell proliferation and microvessel density in
prostate cancer. Clin Cancer Res. 11:4117–4127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Müller A, Homey B, Soto H, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001.PubMed/NCBI
|
|
38.
|
Tanaka T, Bai Z, Srinoulprasert Y, Yang
BG, Hayasaka H and Miyasaka M: Chemokines in tumor progression and
metastasis. Cancer Sci. 96:317–322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Koizumi K, Hojo S, Akashi T, Yasumoto K
and Saiki I: Chemokine receptors in cancer metastasis and cancer
cell-derived chemokines in host immune response. Cancer Sci.
98:1652–1658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Balakin KV, Ivanenkov YA, Tkachenko SE,
Kiselyov AS and Ivachtchenko AV: Regulators of chemokine receptor
activity as promising anticancer therapeutics. Curr Cancer Drug
Targets. 8:299–340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Ruffini PA, Morandi P, Cabioglu N,
Altundag K and Cristofanilli M: Manipulating the
chemokine-chemokine receptor network to treat cancer. Cancer.
109:2392–2404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Kakinuma T and Hwang ST: Chemokines,
chemokine receptors, and cancer metastasis. J Leukoc Biol.
79:639–651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Gabellini C, Trisciuoglio D, Desideri M,
et al: Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on
human malignant melanoma progression. Eur J Cancer. 45:2618–2627.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Roomi MW, Monterrey JC, Kalinovsky T, Rath
M and Niedzwiecki A: Comparative effects of EGCG, green tea and a
nutrient mixture on the patterns of MMP-2 and MMP-9 expression in
cancer cell lines. Oncol Rep. 24:747–757. 2010.PubMed/NCBI
|
|
45.
|
Roomi MW, Monterrey JC, Kalinovsky T, Rath
M and Niedzwiecki A: Patterns of MMP-2 and MMP-9 expression in
human cancer cell lines. Oncol Rep. 21:1323–1333. 2009.PubMed/NCBI
|
|
46.
|
Knall C, Worthen GS and Johnson GL:
Interleukin 8-stimulated phosphatidylinositol-3-kinase activity
regulates the migration of human neutrophils independent of
extracellular signal-regulated kinase and p38 mitogen-activated
protein kinases. Proc Natl Acad Sci USA. 94:3052–3057. 1997.
View Article : Google Scholar
|
|
47.
|
Cheng GZ, Park S, Shu S, et al: Advances
of AKT pathway in human oncogenesis and as a target for anti-cancer
drug discovery. Current Cancer Drug Targets. 8:2–6. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
MacManus CF, Pettigrew J, Seaton A, et al:
Interleukin-8 signaling promotes translational regulation of cyclin
D in androgen-independent prostate cancer cells. Mol Cancer Res.
5:737–748. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Venkatakrishnan G, Salgia R and Groopman
JE: Chemokine receptors CXCR-1/2 activate mitogen-activated protein
kinase via the epidermal growth factor receptor in ovarian cancer
cells. J Biol Chem. 275:6868–6875. 2000. View Article : Google Scholar
|
|
50.
|
Luppi F, Longo AM, de Boer WI, Rabe KF and
Hiemstra PS: Interleukin-8 stimulates cell proliferation in
non-small cell lung cancer through epidermal growth factor receptor
transactivation. Lung Cancer. 56:25–33. 2007. View Article : Google Scholar : PubMed/NCBI
|
